Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Maze Therapeutics, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is Paula A. Johnson, Director (Form 8-K filed 2026-08-17). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Blackrock, Inc. (filed 2026-07-29).
Who is behind it
Maze Therapeutics, Inc.: incorporated in Delaware; business address in South San Francisco, California; industry Biological Products, (No Diagnostic Substances) (Form D, 2026-08-17).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-14 | Paradigm Biocapital Advisors LP | 0% |
| Schedule 13G, 2026-07-29 | Blackrock, Inc. | 5.4% |
| Schedule 13G/A, 2026-05-15 | Janus Henderson Group PLC | 5.8% |
| Schedule 13G, 2026-04-01 | Paradigm Biocapital Advisors LP | 6.1% |
| Schedule 13G/A, 2026-02-13 | Frazier Life Sciences Public Fund, L.P. | 9% |
| Schedule 13G/A, 2026-02-13 | Third Rock Ventures Iv, L.P. | 9.3% |
| Schedule 13G/A, 2026-02-06 | Alphabet Holdings LLC | 2.9% |
| Schedule 13G/A, 2025-11-14 | Janus Henderson Group PLC | 7.3% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-08-17 | Paula A. Johnson | Director | appointed | 2026-08-13 |
| Form 8-K, 2026-08-17 | Herv Hoppenot | Director | departed | 2026-08-13 |
| Form 8-K, 2026-05-22 | Amy Bachrodt | Senior Vice President, Finance | departed | 2026-06-01 |
Money raised
Latest IPO step: Maze Therapeutics, Inc. filed to go public (S-1, 2025-10-17).
IPO filings: S-1, 2025-10-17, 424B4, 2025-01-31, S-1/A, 2025-01-30, S-1/A, 2025-01-27, S-1, 2025-01-07; ticker MAZE on Nasdaq Global Market.
Related pages
Leadership changes5%+ holdersIPO filings
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/maze-therapeuticsLast updated 2026-10-18
Primary record: Schedule 13G, 2026-07-29 · Form 8-K, 2026-08-17 · Form 8-K, 2026-05-22 · S-1, 2025-10-17
Who owns Maze Therapeutics, Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/maze-therapeutics